Saturday, June 21, 2025 6/21/2025

Optimizing functional recovery of breast cancer survivors

Award Number: R01CA225792
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2019
PERIOD OF PERFORMANCE END DATE: 01/31/2025

Group Awards By:

View Award Description

Optimizing functional recovery of breast cancer survivors - PROJECT SUMMARY/ABSTRACT Almost one-third of breast cancer survivors report an inability to fully participate in vocational, social, physical, and instrumental activities of daily living. Breast cancer survivors who report lower participation in these activities report lower quality of life and greater depression, and are at risk for shortened survival. The long- term goal of this research is to address the absence of scalable, accessible, evidence-based interventions that improve cancer survivors' participation in life roles and activities. The objective of this R01 from a new investigator is to test a telephone-delivered, Behavioral Activation/Problem-solving (BA/PS) intervention designed to directly foster activity participation. The BA/PS intervention is a theory-based intervention that was developed over three pilot studies. Over nine sessions, survivors increase or enhance their participation in life roles and activities by setting, adjusting, and achieving goals that incrementally adapt their activities and environments and enhance their personal capacity. This application proposes a randomized controlled trial (RCT) to evaluate the efficacy of BA/PS for improving activity participation as compared to an attention control condition within a sample of 300 breast cancer survivors reporting reduced functioning after completing cancer treatment. In order to maximize diversity, the study will be conducted at two National Cancer Institute- designated Comprehensive Cancer Centers: Norris Cotton Cancer Center at Dartmouth (NH) and the University of Alabama at Birmingham Comprehensive Cancer Center (AL). The study will address three specific aims: (1) To evaluate the effect of BA/PS on participation/productivity in social roles and activities (primary outcome); (2) To evaluate the effect of BA/PS on quality of life; (3) To evaluate the effect of BA/PS on the outcomes of coping, goal adjustment, and distress. The trial is designed to test whether the BA/PS intervention affects the slope of functional recovery over time. The outcome variables listed above are measured at eight, 20, and 44 weeks after study enrollment, allowing the exploration of both immediate and sustained intervention effects. The theory-driven, standardized approach is innovative because it directly promotes resumption of valued activities as identified by each survivor. The telephone delivery method increases the accessibility of the intervention and has the ability to drive the field forward, in contrast to clinic- based interventions that only meet the needs of those survivors with the time and ability to return to an outpatient setting. The proposed research is significant because it helps breast cancer survivors develop strategies to enhance productivity at home, in the workplace, and in the community, and to create sustainable lifestyle changes that foster health, participation, and functional well-being. As such, the knowledge gained from this study has the potential to advance the mission of the Office of Cancer Survivorship (of the National Cancer Institute) by reducing disability and improving the quality of life of cancer survivors.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	THE MGH INSTITUTE OF HEALTH PROFESSIONS, INC.	36 1ST AVE	CHARLESTOWN	MA	02129	SUFFOLK	USA	Cancer Cause and Prevention Research	000	5	4/24/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $584,430 )
2023	2023	MGH INSTITUTE OF HEALTH PROFESSIONS, INC.THE	36 1ST AVE	BOSTON	MA	02129	SUFFOLK	USA	Cancer Cause and Prevention Research	000	5	3/24/2023	NON-COMPETING CONTINUATION	$584,430
														Subtotal = $584,430

Issue Date FY: 2022 ( Subtotal = $595,108 )
2022	2022	MGH INSTITUTE OF HEALTH PROFESSIONS, INC.THE	36 1ST AVE	BOSTON	MA	02129	SUFFOLK	USA	Cancer Cause and Prevention Research	003	4	4/20/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$478,027
2022	2022	MGH INSTITUTE OF HEALTH PROFESSIONS, INC.THE	36 1ST AVE	BOSTON	MA	02129	SUFFOLK	USA	Cancer Cause and Prevention Research	001	4	4/14/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$595,108
2022	2021	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Cancer Cause and Prevention Research	002	3	4/20/2022	NON-COMPETING CONTINUATION	-$478,027
2022	2021	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Cancer Cause and Prevention Research	000	3	4/14/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $595,108

Issue Date FY: 2021 ( Subtotal = $580,853 )
2021	2021	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Cancer Cause and Prevention Research	000	3	1/25/2021	NON-COMPETING CONTINUATION	$580,853
														Subtotal = $580,853

Issue Date FY: 2020 ( Subtotal = $585,028 )
2020	2020	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Cancer Cause and Prevention Research	000	2	1/16/2020	NON-COMPETING CONTINUATION	$585,028
														Subtotal = $585,028

Issue Date FY: 2019 ( Subtotal = $605,720 )
2019	2019	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Cancer Cause and Prevention Research	000	1	1/31/2019	NEW	$605,720
														Subtotal = $605,720

Grand Total All Awards = $2,951,139

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Optimizing functional recovery of breast cancer survivors

Award Number: R01CA225792

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2019

PERIOD OF PERFORMANCE END DATE: 01/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer